* Based on price data for 2018, collected from recognized price sources. Countries included in analysis: United States, United Kingdom, Japan, Canada, Australia, Portugal, France, Netherlands, Germany, Denmark, Sweden, Switzerland. Comparison is with U.S. drug prices under Medicare Part D. Information on types of Multiple Sclerosis medication provided by National Multiple Sclerosis Society.
Citation formats
International multiple sclerosis drug prices in comparison to U.S. 2018
Although there was variation in price between select multiple sclerosis drugs, in all cases the U.S. price per dose was higher than the average of the 11 other countries in this analysis. Avonex, was over 1,400 U.S. dollars more expensive in the U.S. compared to the non-U.S. average price.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
US House of Representatives (Committee on Ways and Means). (September 23, 2019). Price comparison U.S. vs. international per dose for select multiple sclerosis drugs in 2018* (in U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 24, 2026, from /statistics/1134367/ms-drug-prices-international-average-vs-us/
US House of Representatives (Committee on Ways and Means). "Price comparison U.S. vs. international per dose for select multiple sclerosis drugs in 2018* (in U.S. dollars)." Chart. September 23, 2019. ÌÇÐÄÆƽâ°æ. Accessed July 24, 2026. /statistics/1134367/ms-drug-prices-international-average-vs-us/
US House of Representatives (Committee on Ways and Means). (2019). Price comparison U.S. vs. international per dose for select multiple sclerosis drugs in 2018* (in U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 24, 2026. /statistics/1134367/ms-drug-prices-international-average-vs-us/
US House of Representatives (Committee on Ways and Means). "Price Comparison U.S. Vs. International per Dose for Select Multiple Sclerosis Drugs in 2018* (in U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 23 Sep 2019, /statistics/1134367/ms-drug-prices-international-average-vs-us/
US House of Representatives (Committee on Ways and Means), Price comparison U.S. vs. international per dose for select multiple sclerosis drugs in 2018* (in U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1134367/ms-drug-prices-international-average-vs-us/ (last visited July 24, 2026)
Price comparison U.S. vs. international per dose for select multiple sclerosis drugs in 2018* (in U.S. dollars) [Graph], US House of Representatives (Committee on Ways and Means), September 23, 2019. [Online]. Available: /statistics/1134367/ms-drug-prices-international-average-vs-us/
